$NDAQ

Nasdaq (NDAQ) Q2 2026 Earnings Call Transcript

Nasdaq (NDAQ) reported Q2 2026 net revenue of $1.5 billion, up 15%, and non-GAAP EPS of $1.07, up 25%. Solutions revenue rose 17% to $1.2 billion, with Index AUM reaching $1.114 trillion and $51 billion in quarterly net inflows. The company updated non-GAAP operating expense guidance to $2.530 billion to $2.570 billion and repurchased $356 million of shares.

Original reporting
Published Jul 24, 2026, 1:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 1:22 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nasdaq (NDAQ) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$NDAQBullishMed
01

Why it matters

Traders can use the updated non-GAAP operating expense guidance range, the variable accelerated repurchase plan, and the ARR/index inflow metrics to frame near-term estimates and risk around margin trajectory.

02

Market read

The combination of beat-like growth metrics, $1T index AUM milestone, and explicit expense guidance update is likely to drive estimate revisions and positioning.

03

What to watch

The transcript flags specific comp pressures (regulatory fine contra expense in Q3 2025, lower tape plan revenue) that could matter more than headline ARR growth if margins compress.

Relevance 8/10Novelty 7/10Timing: ahead of/around the Q2 earnings release and guidance digestion

Background

Nasdaq’s Q2 2026 earnings call highlights recurring revenue growth, index AUM crossing $1T, and ongoing market modernization plus AI integration across products.

Company-level read

Ticker impact

$NDAQBullishMedium confidence
Context

Nasdaq reported Q2 2026 results with $1.5B revenue (+15%), non-GAAP EPS $1.07 (+25%), and updated non-GAAP operating expense guidance to $2.530B-$2.570B.

Expected impact

Likely positive bias for the stock on earnings-day positioning, with follow-through tied to whether the expense guidance and ARR/index inflows offset the cited tougher comps.

Evidence & confidence

The article provides multiple primary datapoints (revenue, EPS, ARR, inflows, margin, buyback plan, and updated expense guidance) that can drive revisions, though it does not include consensus or the actual stock reaction.

Market effects

Strength in index AUM, options volumes, and recurring revenue supports the exchange/market-infrastructure theme and may lift sentiment for trading-venue peers.

International product launches (50% of new index products outside the US) suggest broader demand beyond US listings.

Large index inflows and record IPO facilitation reinforce global capital-markets activity and could influence cross-border listing and market-data expectations.

Counterpoint

Growth may decelerate in near quarters due to non-recurring revenue timing (Calypso upfront) and headwinds from lower tape plan/audit-related revenue and tougher expense comps.

Key entities

  • Nasdaq, Inc.

    Reported Q2 2026 revenue, EPS, ARR, index AUM, and updated non-GAAP operating expense guidance, plus a new buyback plan.

  • Adena Friedman

    CEO who characterized the SpaceX listing as a historic milestone and discussed product launches and AI adoption.

  • Sarah Youngwood

    CFO who provided guidance updates and highlighted comp headwinds and expense comparisons.

Related articles

$NDAQMed

SEC sets Aug. 24 deadline in Nasdaq Bitcoin options review

The SEC ordered a full Commission review of Nasdaq PHLX’s proposed cash-settled Bitcoin index options (QBTC), after CME Group petitioned against a May 22 staff approval. The SEC set Aug. 24 as the deadline for written comments. The May approval remains stayed pending the Commission’s next order, with CFTC and OCC relief still required.

$CMEMed

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction — BigGo Finance

CME Group challenged the SEC’s conditional approval of Nasdaq PHLX’s cash-settled bitcoin index options (ticker QBTC). CME says bitcoin is a commodity, so CFTC has exclusive jurisdiction, and the SEC exceeded its authority. The SEC initiated review and kept a stay. Comments are due Aug. 24. QBTC uses CME CF Bitcoin Real-Time Index and is cash-settled in USD.

$NDAQMedAI 9/10

Nasdaq Q2 Earnings: Double-Digit Revenue Growth Across All Divisions

Nasdaq (NDAQ) reported Q2 results with quarterly net revenue of $1.5 billion, up 15% on an adjusted basis. Solutions revenue rose 17% adjusted. ARR increased 11% to $3.3 billion. GAAP diluted EPS was $0.89, up 14%, and non-GAAP EPS was $1.07. Nasdaq also cited record Index AUM and IPO activity, including SpaceX.

$NDAQMed

Nasdaq Q2 2026 earnings beat on SpaceX IPO, data revenue

Nasdaq reported Q2 2026 net revenue of $1.5 billion, up 15%, and adjusted EPS of $1.07 versus $0.98 expected, according to Reuters. Capital access platforms revenue rose 19% to $621 million, helped by listing activity including SpaceX’s IPO. Market services and fintech revenue also increased. Nasdaq declared a $0.31 quarterly dividend.